Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 160

1.

Long-term safety and efficacy of deutetrabenazine for the treatment of tardive dyskinesia.

Fernandez HH, Stamler D, Davis MD, Factor SA, Hauser RA, Jimenez-Shahed J, Ondo WG, Jarskog LF, Woods SW, Bega D, LeDoux MS, Shprecher DR, Anderson KE.

J Neurol Neurosurg Psychiatry. 2019 Jul 10. pii: jnnp-2018-319918. doi: 10.1136/jnnp-2018-319918. [Epub ahead of print]

2.

Clinical features and subtypes of restless legs syndrome in Chinese population: a study of 359 patients.

Zhu XY, Wu TT, Wang HM, Ni LY, Li X, Liu Y, Zhang XJ, Chen YJ, Cui XX, Ondo WG, Wu YC.

Sleep Med. 2019 Jul;59:15-23. doi: 10.1016/j.sleep.2019.01.053. Epub 2019 Mar 11.

PMID:
31153012
3.

Restless legs syndrome in end stage renal disease patients undergoing hemodialysis.

Lin XW, Zhang JF, Qiu MY, Ni LY, Yu HL, Kuo SH, Ondo WG, Yu Q, Wu YC.

BMC Neurol. 2019 Mar 29;19(1):47. doi: 10.1186/s12883-019-1265-y.

4.

46 Confirmed Safety of Deutetrabenazine for Tardive Dyskinesia in a 2-Year Open-label Extension Study.

Fernandez HH, Stamler D, Davis MD, Factor SA, Hauser RA, Jimenez-Shahed J, Ondo WG, Jarskog LF, Woods SW, LeDoux MS, Shprecher DR, Anderson KE.

CNS Spectr. 2019 Feb;24(1):201. doi: 10.1017/S1092852919000397.

PMID:
30859974
5.

45 Long-term Treatment with Deutetrabenazine Is Associated with Continued Improvement in Tardive Dyskinesia: Results from an Open-label Extension Study.

Hauser RA, Fernandez HH, Stamler D, Davis MD, Factor SA, Jimenez-Shahed J, Ondo WG, Jarskog LF, Woods SW, LeDoux MS, Shprecher DR, Anderson KE.

CNS Spectr. 2019 Feb;24(1):200-201. doi: 10.1017/S1092852919000385.

PMID:
30859973
6.

In Reply-Additional Safety Considerations Before Prescribing Opioids to Manage Restless Legs Syndrome.

Silber MH, Becker PM, Buchfuhrer MJ, Earley CJ, Ondo WG, Walters AS, Winkelman JW.

Mayo Clin Proc. 2018 Jul;93(7):955-956. doi: 10.1016/j.mayocp.2018.03.021. No abstract available.

PMID:
29976378
7.

Non-VMAT2 inhibitor treatments for the treatment of tardive dyskinesia.

Lin CC, Ondo WG.

J Neurol Sci. 2018 Jun 15;389:48-54. doi: 10.1016/j.jns.2018.02.014. Epub 2018 Feb 5. Review.

PMID:
29433806
8.

Treating Hallucinations and Delusions Associated With Parkinson's Disease Psychosis.

Panchal SC, Ondo WG.

Curr Psychiatry Rep. 2018 Jan 27;20(1):3. doi: 10.1007/s11920-018-0869-z. Review.

PMID:
29374325
9.

Onabotulinum toxin-A injections for sleep bruxism: A double-blind, placebo-controlled study.

Ondo WG, Simmons JH, Shahid MH, Hashem V, Hunter C, Jankovic J.

Neurology. 2018 Feb 13;90(7):e559-e564. doi: 10.1212/WNL.0000000000004951. Epub 2018 Jan 17.

PMID:
29343468
10.

The Appropriate Use of Opioids in the Treatment of Refractory Restless Legs Syndrome.

Silber MH, Becker PM, Buchfuhrer MJ, Earley CJ, Ondo WG, Walters AS, Winkelman JW; Scientific and Medical Advisory Board, Restless Legs Syndrome Foundation.

Mayo Clin Proc. 2018 Jan;93(1):59-67. doi: 10.1016/j.mayocp.2017.11.007.

PMID:
29304922
11.

Clinical features of Parkinson's disease with and without rapid eye movement sleep behavior disorder.

Liu Y, Zhu XY, Zhang XJ, Kuo SH, Ondo WG, Wu YC.

Transl Neurodegener. 2017 Dec 21;6:35. doi: 10.1186/s40035-017-0105-5. eCollection 2017.

12.

Identification of novel risk loci for restless legs syndrome in genome-wide association studies in individuals of European ancestry: a meta-analysis.

Schormair B, Zhao C, Bell S, Tilch E, Salminen AV, Pütz B, Dauvilliers Y, Stefani A, Högl B, Poewe W, Kemlink D, Sonka K, Bachmann CG, Paulus W, Trenkwalder C, Oertel WH, Hornyak M, Teder-Laving M, Metspalu A, Hadjigeorgiou GM, Polo O, Fietze I, Ross OA, Wszolek Z, Butterworth AS, Soranzo N, Ouwehand WH, Roberts DJ, Danesh J, Allen RP, Earley CJ, Ondo WG, Xiong L, Montplaisir J, Gan-Or Z, Perola M, Vodicka P, Dina C, Franke A, Tittmann L, Stewart AFR, Shah SH, Gieger C, Peters A, Rouleau GA, Berger K, Oexle K, Di Angelantonio E, Hinds DA, Müller-Myhsok B, Winkelmann J; 23andMe Research Team; DESIR study group.

Lancet Neurol. 2017 Nov;16(11):898-907. doi: 10.1016/S1474-4422(17)30327-7. Review.

13.

Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial.

Anderson KE, Stamler D, Davis MD, Factor SA, Hauser RA, Isojärvi J, Jarskog LF, Jimenez-Shahed J, Kumar R, McEvoy JP, Ochudlo S, Ondo WG, Fernandez HH.

Lancet Psychiatry. 2017 Aug;4(8):595-604. doi: 10.1016/S2215-0366(17)30236-5. Epub 2017 Jun 28.

PMID:
28668671
14.

Randomized controlled trial of deutetrabenazine for tardive dyskinesia: The ARM-TD study.

Fernandez HH, Factor SA, Hauser RA, Jimenez-Shahed J, Ondo WG, Jarskog LF, Meltzer HY, Woods SW, Bega D, LeDoux MS, Shprecher DR, Davis C, Davis MD, Stamler D, Anderson KE.

Neurology. 2017 May 23;88(21):2003-2010. doi: 10.1212/WNL.0000000000003960. Epub 2017 Apr 26.

15.

Optimizing extended-release carbidopa/levodopa in Parkinson disease: Consensus on conversion from standard therapy.

Espay AJ, Pagan FL, Walter BL, Morgan JC, Elmer LW, Waters CH, Agarwal P, Dhall R, Ondo WG, Klos KJ, Silver DE.

Neurol Clin Pract. 2017 Feb;7(1):86-93. doi: 10.1212/CPJ.0000000000000316. Review.

16.

Clinical and demographic characteristics related to onset site and spread of cervical dystonia.

Norris SA, Jinnah HA, Espay AJ, Klein C, Brüggemann N, Barbano RL, Malaty IA, Rodriguez RL, Vidailhet M, Roze E, Reich SG, Berman BD, LeDoux MS, Richardson SP, Agarwal P, Mari Z, Ondo WG, Shih LC, Fox SH, Berardelli A, Testa CM, Cheng FC, Truong D, Nahab FB, Xie T, Hallett M, Rosen AR, Wright LJ, Perlmutter JS.

Mov Disord. 2016 Dec;31(12):1874-1882. doi: 10.1002/mds.26817. Epub 2016 Oct 18.

17.

Depth and Distribution of Symptoms in Restless Legs Syndrome/ Willis-Ekbom Disease.

Yeh P, Ondo WG, Picchietti DL, Poceta JS, Allen RP, Davies CR, Wang L, Shi Y, Bagai K, Walters AS.

J Clin Sleep Med. 2016 Dec 15;12(12):1669-1680. doi: 10.5664/jcsm.6356.

18.

A Randomized Trial of Focused Ultrasound Thalamotomy for Essential Tremor.

Elias WJ, Lipsman N, Ondo WG, Ghanouni P, Kim YG, Lee W, Schwartz M, Hynynen K, Lozano AM, Shah BB, Huss D, Dallapiazza RF, Gwinn R, Witt J, Ro S, Eisenberg HM, Fishman PS, Gandhi D, Halpern CH, Chuang R, Butts Pauly K, Tierney TS, Hayes MT, Cosgrove GR, Yamaguchi T, Abe K, Taira T, Chang JW.

N Engl J Med. 2016 Aug 25;375(8):730-9. doi: 10.1056/NEJMoa1600159.

19.

Efficacy of gabapentin enacarbil in adult patients with severe primary restless legs syndrome.

Lee DO, Buchfuhrer MJ, Garcia-Borreguero D, Avidan AY, Ahmed M, Hays R, Ondo WG, Jaros MJ, Kim R, Shang G.

Sleep Med. 2016 Mar;19:50-6. doi: 10.1016/j.sleep.2015.11.002. Epub 2015 Nov 14.

PMID:
27198947
20.

A novel scale to assess psychosis in patients with parkinson's disease.

Ondo WG, Sarfaraz S, Lee M.

J Clin Mov Disord. 2015 Dec 1;2:17. doi: 10.1186/s40734-015-0024-5. eCollection 2015.

21.

Effect of prior exposure to dopamine agonists on treatment with gabapentin enacarbil in adults with moderate-to-severe primary restless legs syndrome: pooled analyses from 3 randomized trials.

Ondo WG, Hermanowicz N, Borreguero DG, Jaros MJ, Kim R, Shang G.

J Clin Mov Disord. 2015 Mar 30;2:9. doi: 10.1186/s40734-015-0018-3. eCollection 2015.

23.

Clinical characteristics of leg restlessness in Parkinson's disease compared with idiopathic Restless Legs Syndrome.

Zhu XY, Liu Y, Zhang XJ, Yang WH, Feng Y, Ondo WG, Tan EK, Wu YC.

J Neurol Sci. 2015 Oct 15;357(1-2):109-14. doi: 10.1016/j.jns.2015.07.008. Epub 2015 Jul 9.

PMID:
26189051
24.

Does idiopathic restless legs syndrome delay onset and reduce severity of Parkinson's disease: a pilot study.

Dragan EM, Chen Z, Ondo WG.

Int J Neurosci. 2015;125(7):526-30. doi: 10.3109/00207454.2014.987771. Epub 2014 Dec 18.

PMID:
25405536
25.

Restless legs syndrome: pathophysiology and treatment.

Ondo WG.

Curr Treat Options Neurol. 2014 Nov;16(11):317. doi: 10.1007/s11940-014-0317-2.

PMID:
25238731
26.

Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance.

Allen RP, Picchietti DL, Garcia-Borreguero D, Ondo WG, Walters AS, Winkelman JW, Zucconi M, Ferri R, Trenkwalder C, Lee HB; International Restless Legs Syndrome Study Group.

Sleep Med. 2014 Aug;15(8):860-73. doi: 10.1016/j.sleep.2014.03.025. Epub 2014 May 17.

PMID:
25023924
27.

Sleep/wake problems in Parkinson's disease: pathophysiology and clinicopathologic correlations.

Ondo WG.

J Neural Transm (Vienna). 2014 Aug;121 Suppl 1:S3-13. doi: 10.1007/s00702-014-1239-6. Epub 2014 May 25. Review.

PMID:
24858728
28.

Effects of deep brain stimulation in relatively young-onset multiple system atrophy Parkinsonism.

Zhu XY, Pan TH, Ondo WG, Jimenez-Shahed J, Wu YC.

J Neurol Sci. 2014 Jul 15;342(1-2):42-4. doi: 10.1016/j.jns.2014.04.022. Epub 2014 Apr 29.

PMID:
24831987
29.

Orthostatic tremor: a review of 45 cases.

Yaltho TC, Ondo WG.

Parkinsonism Relat Disord. 2014 Jul;20(7):723-5. doi: 10.1016/j.parkreldis.2014.03.013. Epub 2014 Mar 21. Review.

PMID:
24736049
30.

Common comorbidities and differential diagnosis of restless legs syndrome.

Ondo WG.

J Clin Psychiatry. 2014 Mar;75(3):e06. doi: 10.4088/JCP.12074nr2c.

31.

A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit.

Parkinson Study Group QE3 Investigators, Beal MF, Oakes D, Shoulson I, Henchcliffe C, Galpern WR, Haas R, Juncos JL, Nutt JG, Voss TS, Ravina B, Shults CM, Helles K, Snively V, Lew MF, Griebner B, Watts A, Gao S, Pourcher E, Bond L, Kompoliti K, Agarwal P, Sia C, Jog M, Cole L, Sultana M, Kurlan R, Richard I, Deeley C, Waters CH, Figueroa A, Arkun A, Brodsky M, Ondo WG, Hunter CB, Jimenez-Shahed J, Palao A, Miyasaki JM, So J, Tetrud J, Reys L, Smith K, Singer C, Blenke A, Russell DS, Cotto C, Friedman JH, Lannon M, Zhang L, Drasby E, Kumar R, Subramanian T, Ford DS, Grimes DA, Cote D, Conway J, Siderowf AD, Evatt ML, Sommerfeld B, Lieberman AN, Okun MS, Rodriguez RL, Merritt S, Swartz CL, Martin WR, King P, Stover N, Guthrie S, Watts RL, Ahmed A, Fernandez HH, Winters A, Mari Z, Dawson TM, Dunlop B, Feigin AS, Shannon B, Nirenberg MJ, Ogg M, Ellias SA, Thomas CA, Frei K, Bodis-Wollner I, Glazman S, Mayer T, Hauser RA, Pahwa R, Langhammer A, Ranawaya R, Derwent L, Sethi KD, Farrow B, Prakash R, Litvan I, Robinson A, Sahay A, Gartner M, Hinson VK, Markind S, Pelikan M, Perlmutter JS, Hartlein J, Molho E, Evans S, Adler CH, Duffy A, Lind M, Elmer L, Davis K, Spears J, Wilson S, Leehey MA, Hermanowicz N, Niswonger S, Shill HA, Obradov S, Rajput A, Cowper M, Lessig S, Song D, Fontaine D, Zadikoff C, Williams K, Blindauer KA, Bergholte J, Propsom CS, Stacy MA, Field J, Mihaila D, Chilton M, Uc EY, Sieren J, Simon DK, Kraics L, Silver A, Boyd JT, Hamill RW, Ingvoldstad C, Young J, Thomas K, Kostyk SK, Wojcieszek J, Pfeiffer RF, Panisset M, Beland M, Reich SG, Cines M, Zappala N, Rivest J, Zweig R, Lumina LP, Hilliard CL, Grill S, Kellermann M, Tuite P, Rolandelli S, Kang UJ, Young J, Rao J, Cook MM, Severt L, Boyar K.

JAMA Neurol. 2014 May;71(5):543-52. doi: 10.1001/jamaneurol.2014.131.

PMID:
24664227
32.

Willis-Ekbom Disease Foundation revised consensus statement on the management of restless legs syndrome.

Silber MH, Becker PM, Earley C, Garcia-Borreguero D, Ondo WG; Medical Advisory Board of the Willis-Ekbom Disease Foundation.

Mayo Clin Proc. 2013 Sep;88(9):977-86. doi: 10.1016/j.mayocp.2013.06.016.

PMID:
24001490
33.

Paraspinal muscle asymmetry in Parkinson's disease.

Ondo WG, Haykal HA.

Int J Neurosci. 2014 Feb;124(2):93-6. doi: 10.3109/00207454.2013.825259. Epub 2013 Aug 22.

PMID:
23865391
34.

Predictors of placebo response in restless legs syndrome studies.

Ondo WG, Hossain MM, Gordon MF, Reess J.

Neurology. 2013 Jul 9;81(2):193-4. doi: 10.1212/WNL.0b013e31829a33bd. Epub 2013 Jun 7. No abstract available.

PMID:
23749799
35.

Movements Mimicking Myoclonus Associated with Spinal Cord Pathology: Is this a "Pure Motor Restless Legs Syndrome".

Ondo WG.

Tremor Other Hyperkinet Mov (N Y). 2012;2. pii: tre-02-34-107-1. doi: 10.7916/D8M61J0P. Epub 2012 Mar 20.

36.

Globus pallidus deep brain stimulation for refractory idiopathic restless legs syndrome.

Ondo WG, Jankovic J, Simpson R, Jimenez-Shahed J.

Sleep Med. 2012 Oct;13(9):1202-4. doi: 10.1016/j.sleep.2012.06.007. Epub 2012 Sep 18.

PMID:
22995627
37.

Tetrabenazine treatment for stereotypies and tics associated with dementia.

Ondo WG.

J Neuropsychiatry Clin Neurosci. 2012 Spring;24(2):208-14. doi: 10.1176/appi.neuropsych.11030077.

PMID:
22772669
38.

Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature.

Chen JJ, Ondo WG, Dashtipour K, Swope DM.

Clin Ther. 2012 Jul;34(7):1487-504. doi: 10.1016/j.clinthera.2012.06.010. Epub 2012 Jun 28. Review.

PMID:
22749259
39.

Effect of tetrabenazine on computerized dynamic posturography in Huntington disease patients.

Fekete R, Davidson A, Ondo WG, Cohen HS.

Parkinsonism Relat Disord. 2012 Aug;18(7):896-8. doi: 10.1016/j.parkreldis.2012.04.029. Epub 2012 May 22.

40.

Placebo-controlled trial of lubiprostone for constipation associated with Parkinson disease.

Ondo WG, Kenney C, Sullivan K, Davidson A, Hunter C, Jahan I, McCombs A, Miller A, Zesiewicz TA.

Neurology. 2012 May 22;78(21):1650-4. doi: 10.1212/WNL.0b013e3182574f28. Epub 2012 May 9.

PMID:
22573627
41.

Apomorphine injections: predictors of initial common adverse events and long term tolerability.

Ondo WG, Hunter C, Ferrara JM, Mostile G.

Parkinsonism Relat Disord. 2012 Jun;18(5):619-22. doi: 10.1016/j.parkreldis.2012.01.001. Epub 2012 Jan 27.

PMID:
22284728
42.

Dextromethorphan/quinidine for chorea: an open-label assessment.

Ondo WG.

Clin Neuropharmacol. 2012 Jan-Feb;35(1):53-4. doi: 10.1097/WNF.0b013e31823d78c4. No abstract available.

PMID:
22240863
43.

Stereotypies as a manifestation of acute hyperglycemia without ketosis.

Baizabal-Carvallo JF, Ondo WG.

J Neurol Sci. 2012 Apr 15;315(1-2):176-7. doi: 10.1016/j.jns.2011.11.014. Epub 2011 Nov 26.

PMID:
22123156
44.

Motor complications in Parkinson's disease.

Ondo WG.

Int J Neurosci. 2011;121 Suppl 2:37-44. doi: 10.3109/00207454.2011.620198. Review.

PMID:
22035028
45.

Evidence-based guideline update: treatment of essential tremor: report of the Quality Standards subcommittee of the American Academy of Neurology.

Zesiewicz TA, Elble RJ, Louis ED, Gronseth GS, Ondo WG, Dewey RB Jr, Okun MS, Sullivan KL, Weiner WJ.

Neurology. 2011 Nov 8;77(19):1752-5. doi: 10.1212/WNL.0b013e318236f0fd. Epub 2011 Oct 19. Review.

46.

Task-specific writing tremor: clinical phenotypes, progression, treatment outcomes, and proposed nomenclature.

Ondo WG, Satija P.

Int J Neurosci. 2012 Feb;122(2):88-91. doi: 10.3109/00207454.2011.630544. Epub 2011 Nov 15.

PMID:
21985650
47.

Association studies of variants in MEIS1, BTBD9, and MAP2K5/SKOR1 with restless legs syndrome in a US population.

Yang Q, Li L, Chen Q, Foldvary-Schaefer N, Ondo WG, Wang QK.

Sleep Med. 2011 Sep;12(8):800-4. doi: 10.1016/j.sleep.2011.06.006.

48.

Genome-wide association study identifies novel restless legs syndrome susceptibility loci on 2p14 and 16q12.1.

Winkelmann J, Czamara D, Schormair B, Knauf F, Schulte EC, Trenkwalder C, Dauvilliers Y, Polo O, Högl B, Berger K, Fuhs A, Gross N, Stiasny-Kolster K, Oertel W, Bachmann CG, Paulus W, Xiong L, Montplaisir J, Rouleau GA, Fietze I, Vávrová J, Kemlink D, Sonka K, Nevsimalova S, Lin SC, Wszolek Z, Vilariño-Güell C, Farrer MJ, Gschliesser V, Frauscher B, Falkenstetter T, Poewe W, Allen RP, Earley CJ, Ondo WG, Le WD, Spieler D, Kaffe M, Zimprich A, Kettunen J, Perola M, Silander K, Cournu-Rebeix I, Francavilla M, Fontenille C, Fontaine B, Vodicka P, Prokisch H, Lichtner P, Peppard P, Faraco J, Mignot E, Gieger C, Illig T, Wichmann HE, Müller-Myhsok B, Meitinger T.

PLoS Genet. 2011 Jul;7(7):e1002171. doi: 10.1371/journal.pgen.1002171. Epub 2011 Jul 14. Erratum in: PLoS Genet. 2011 Aug;7(8). doi: 10.1371/annotation/393ad2d3-df4f-4770-87bc-00bfabf79362.

49.

Improvements in nocturnal symptoms with ropinirole prolonged release in patients with advanced Parkinson's disease.

Ray Chaudhuri K, Martinez-Martin P, Rolfe KA, Cooper J, Rockett CB, Giorgi L, Ondo WG.

Eur J Neurol. 2012 Jan;19(1):105-13. doi: 10.1111/j.1468-1331.2011.03442.x. Epub 2011 Jun 23.

PMID:
21699627
50.

Intrastriatal transplantation of microcarrier-bound human retinal pigment epithelial cells versus sham surgery in patients with advanced Parkinson's disease: a double-blind, randomised, controlled trial.

Gross RE, Watts RL, Hauser RA, Bakay RA, Reichmann H, von Kummer R, Ondo WG, Reissig E, Eisner W, Steiner-Schulze H, Siedentop H, Fichte K, Hong W, Cornfeldt M, Beebe K, Sandbrink R; Spheramine Investigational Group.

Lancet Neurol. 2011 Jun;10(6):509-19. doi: 10.1016/S1474-4422(11)70097-7. Epub 2011 May 10.

PMID:
21565557

Supplemental Content

Support Center